SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-24-001818
Filing Date
2024-03-28
Accepted
2024-03-28 16:05:40
Documents
79
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR FYE END DEC 2023 sunshine_i10k-123123.htm   iXBRL 10-K 920324
2 LIST OF SUBSIDIARIES sunshine_ex2101.htm EX-21.1 2111
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM sunshine_ex2301.htm EX-23.1 2369
4 CERTIFICATION sunshine_ex3101.htm EX-31.1 8460
5 CERTIFICATION sunshine_ex3102.htm EX-31.2 8443
6 CERTIFICATION sunshine_ex3201.htm EX-32.1 3907
7 CLAWBACK POLICY sunshine_ex9701.htm EX-97.1 51418
8 GRAPHIC image_001.jpg GRAPHIC 6215
14 GRAPHIC image_002.jpg GRAPHIC 6733
  Complete submission text file 0001683168-24-001818.txt   5037125

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE sbfm-20231231.xsd EX-101.SCH 40508
10 XBRL CALCULATION FILE sbfm-20231231_cal.xml EX-101.CAL 56832
11 XBRL DEFINITION FILE sbfm-20231231_def.xml EX-101.DEF 164328
12 XBRL LABEL FILE sbfm-20231231_lab.xml EX-101.LAB 354903
13 XBRL PRESENTATION FILE sbfm-20231231_pre.xml EX-101.PRE 302917
82 EXTRACTED XBRL INSTANCE DOCUMENT sunshine_i10k-123123_htm.xml XML 519191
Mailing Address 1177 AVENUE OF THE AMERICAS 5TH FLOOR NEW YORK NY 10036
Business Address 1177 AVENUE OF THE AMERICAS 5TH FLOOR NEW YORK NY 10036 332-216-1147
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

IRS No.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41282 | Film No.: 24798799
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)